ACS Infectious DiseasesMicrobiologyPeer-reviewed journal article
BDF6 deficiency severely compromises intracellular amastigotes development and infectivity in Trypanosoma cruzi
Victoria BoselliiD, Virginia PerdomoiD, Florencia Pacini, Juan Agustín Cueto, Alejandro Pezza, Romano Patricia, Roberto DocampoiD, Ana Rosa PéreziD, Esteban Carlos SerraiD
Abstract
Trypanosoma cruzi, the causative agent of Chagas disease, relies on complex gene regulatory mechanisms to adapt to its diverse host environments. In recent years, it has been established that epigenetics plays an essential role in these mechanisms via the regulation of chromatin structure. Bromodomain-containing factors (BDFs), known for recognizing acetylated lysines on histones, have emerged as key factors in chromatin remodeling complexes. Among the eight predicted BDFs in T. cruzi, BDF6 is part of a TINTIN-like complex with MRGx and MRGBP, homologous to components of the NuA4/TIP60 chromatin remodeling complex. We generated knockout (KO) parasites for bdf6 gene using CRISPR/Cas9 gene editing. BDF6-deficient epimastigotes exhibit normal morphology but decreased size and growth and the resulting metacyclic trypomastigotes displayed drastically reduced infectivity. Strikingly, once inside host cells, BDF6-deficient parasites differentiated into amastigotes but failed to replicate. This intracellular arrest was reversed by episomal complementation of BDF6. Consistently, BDF6-KO parasites also exhibited impaired infectivity in mice, a defect that was also rescued in the add back parasite strains. Our findings highlight BDF6 as a critical regulator of intracellular parasite development, operating in stages beyond epimastigotes where epigenetic plasticity is essential for host adaptation. This striking stage-specific phenotype of BDF6 KO underscores its functional importance and highlights the relevance of epigenetic regulators along T. cruzis life cycle.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- top 27%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Essential bromodomain TcBDF2 as a drug target against Chagas disease
A. Pezza, L. E. Tavernelli, … E. Serra·bioRxiv·Jan 25, 2022
- Reduced levels of inositol hexakisphosphate kinase (IP6K) impair life-cycle transitions and the intracellular development of Trypanosoma cruzi within human cardiomyocytes
Bryan E. Abuchery, Thaíse Lara Teixeira, … Marcelo S. da Silva·bioRxiv·May 29, 2026
- Structural Insights into Bromodomain-Containing Complexes from Trypanosoma cruzi Revealed by Proximity Labeling and Stoichiometric Space Exploration
Elvio Rodríguez Araya, Gonzalo Martinez Peralta, … Esteban Carlos Serra·bioRxiv·Mar 31, 2026
- Intracellular DNA replication and differentiation of Trypanosoma cruzi is asynchronous within individual host cells in vivo at all stages of infection
M. C. Taylor, A. Ward, … J. M. Kelly·PLOS Neglected Tropical DiseasesPeer-reviewed·Mar 20, 2020
- The bromodomain protein Bdf3 is sufficient to activate expression of a procyclin gene in bloodstream stage African trypanosomes
Evan J Kim, Ethan L Goroza, … Danae Schulz·mSpherePeer-reviewed·Jun 1, 2026
- Glycosomal phosphoenolpyruvate carboxykinase CRISPR/Cas9-deletion and its role in Trypanosoma cruzi metacyclogenesis and infectivity in mammalian host
Carolina Silva Dias Vieira, Wei Wang, … Natália Pereira de Almeida Nogueira·The FASEB JournalPeer-reviewed·Mar 11, 2026